$1.59
0.2216.06%
Last update: Nov 11, 7:10 PM
Aardvark Therapeutics Inc
AARDNASDAQ
Aardvark Therapeutics fell 87.6% from $11.06 to $1.37, behind the S&P 500's +11.2%. Its worst day was Oct 23 (−64.8%), and its low came Oct 26 at $1.08.
Nov 11, 2025 – Nov 10, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.75 beat the $-0.81 estimate on $0.00 revenue.
−8.7% · S&P 500 0.0%
Aardvark Therapeutics closed at its highest level of the year, 43.0% above where the year started.
Story events cover the past 12 months · Times ET
+1.9% · S&P 500 +1.2%
Aardvark Therapeutics shares fell 56.2%, while the S&P 500 rose 0.1%.
−56.2% · S&P 500 +0.1%
EPS of $-0.81 beat the $-0.82 estimate on $0.00 revenue.
−7.3% · S&P 500 −0.3%
EPS of $-0.99 missed the $-0.89 estimate on $0.00 revenue.
−4.9% · S&P 500 −0.3%
Aardvark Therapeutics shares fell 32.1%, while the S&P 500 fell 1.2%.
−32.1% · S&P 500 −1.2%
Aardvark Therapeutics shares rose 52.0%, while the S&P 500 rose 0.4%.
+52.0%, the year's best day · S&P 500 +0.4%
EPS of $-0.66 beat the $-0.88 estimate on $0.00 revenue.
−8.6% · S&P 500 +0.3%
Aardvark Therapeutics closed at its lowest level of the year, 90.2% below where the year started.
−22.3% · S&P 500 +0.7%
Where it ended: a close of $1.37 on Nov 10, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.74).
Nothing in the past 12 months.
All AARD dividend historyReplay the year: the line draws itself and stops at each of the 9 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for AARD and SPY from Benzinga historical bars. Not investment advice.
